Richard R. Deluca has sold MRK and made no open-market buys since Nov 2018

Richard R. DeLuca, Jr. is Executive Vice President and President of Merck Animal Health at Merck & Co., Inc. (MRK), a role he has held since September 15, 2011, overseeing the global animal health business that provides veterinary pharmaceuticals, vaccines, health management solutions, and digital products in over 150 markets.( Under his leadership, the division has become an industry leader with approximately 7,000 employees worldwide and annual revenues exceeding $3 billion.(

DeLuca, aged 62 with 13 years of tenure at Merck, brings over 30 years of experience in finance, sales, and management, including 15 years in pharmaceuticals.( Prior to Merck, he served as CFO of BD Biosciences (2010), President of Wyeth's Fort Dodge Animal Health (2007–2010, >$1B revenue), COO (2006–2007), and EVP/CFO (2002–2006), with earlier roles since 1982.( He holds a B.A. in business administration from Widener University and is a certified public accountant and management accountant.( DeLuca chairs the Animal Health Institute (since 2016) and formerly chaired Health for Animals (2017–2020).( Recently, as an insider, he sold 37,685 MRK shares for $4.56 million.(

Written by Perplexity from public sources.